Three-factor prediction model for Grade 2+ Cytokine Release Syndrome in Large B Cell Lymphoma Patients Receiving Epcoritamab Monotherapy

Kim Linton, et al.

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Journal	Blood
Volume	144
Issue number	S1
DOIs	https://doi.org/10.1182/blood-2024-200957
Publication status	Published - 5 Nov 2024
Event	66th ASH Annual Meeting & Exposition - San Diego, United States Duration: 7 Dec 2024 → 10 Dec 2024 https://www.hematology.org/meetings/annual-meeting/schedule-and-program

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{4425329b788e4c4ca03bf7c1f955d535,

title = "Three-factor prediction model for Grade 2+ Cytokine Release Syndrome in Large B Cell Lymphoma Patients Receiving Epcoritamab Monotherapy",

author = "Kim Linton and {et al.}",

year = "2024",

month = nov,

day = "5",

doi = "10.1182/blood-2024-200957",

language = "English",

volume = "144",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier BV",

number = "S1",

note = "66th ASH Annual Meeting & Exposition ; Conference date: 07-12-2024 Through 10-12-2024",

url = "https://www.hematology.org/meetings/annual-meeting/schedule-and-program",

}

TY - JOUR

T1 - Three-factor prediction model for Grade 2+ Cytokine Release Syndrome in Large B Cell Lymphoma Patients Receiving Epcoritamab Monotherapy

AU - Linton, Kim

AU - et al.,

PY - 2024/11/5

Y1 - 2024/11/5

U2 - 10.1182/blood-2024-200957

DO - 10.1182/blood-2024-200957

M3 - Meeting Abstract

SN - 0006-4971

VL - 144

JO - Blood

JF - Blood

IS - S1

T2 - 66th ASH Annual Meeting & Exposition

Y2 - 7 December 2024 through 10 December 2024

ER -